Pharmaxis Ltd (PXS)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 394.32m

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 30-Jun-10 30-Jun-09 30-Jun-08 30-Jun-07 30-Jun-06
Continuing Operations          
Revenue 0.83 0.60 0.53 0.20 0.01
Operating Profit/(Loss) (49.38) (40.35) (27.81) (24.16) (17.73)
Profit Before Tax (46.29) (35.12) (20.41) (24.16) (17.73)
Profit After Tax (46.35) (35.17) (20.44) (24.18) n/a
           
Earnings per Share - Basic (19.99¢) (17.14¢) (10.28¢) (12.95¢) (10.57¢)
Earnings per Share - Adjusted (19.99¢) (17.14¢) (10.28¢) (12.95¢) (10.57¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 30-Jun-10 30-Jun-09 30-Jun-08 30-Jun-07 30-Jun-06
Assets          
Non-Current Assets          
Property, Plant & Equipment 32.54 32.70 3.67 3.52 3.20
Intangible Assets 17.70 1.19 1.23 1.24 1.20
Other Non-Current Assets 1.61 3.64 1.57 0.60 0.56
  51.85 37.53 6.46 5.36 4.96
Current Assets          
Inventories 0.42 0.25 0.10 0.08 0.10
Cash at Bank & in Hand 85.79 124.99 111.84 76.18 97.84
Other Current Assets 2.71 1.22 6.65 1.03 1.37
  88.92 126.47 118.59 77.29 99.31
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 140.77 164.00 125.05 82.65 104.27
Current Liabilities          
Borrowings 0.37 0.32 n/a n/a n/a
Other Current Liabilities 8.80 8.88 5.74 5.97 5.31
           
Current Liabilities 9.17 9.20 5.74 5.97 5.31
           
Net Current Assets c79.75 c117.27 c112.85 c71.31 c94.00
           
Borrowings 13.16 13.56 n/a n/a n/a
Other Non-Current Liabilities 3.42 3.55 0.19 0.12 0.07
Non-Current Liabilities 16.58 17.11 0.19 0.12 0.07
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 25.75 26.31 5.93 6.09 5.38
           
Net Assets 115.02 137.69 119.12 76.56 98.89
           
Shareholders Funds 115.02 137.69 119.12 76.56 98.89
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 115.02 137.69 119.12 76.56 98.89
Cash Flow 30-Jun-10 30-Jun-09 30-Jun-08 30-Jun-07 30-Jun-06
Net Cash Flow From Operating Activities (39.68) (26.47) (18.85) (20.70) (13.77)
Net Cash Flow from Investing Activities 1.14 (11.54) (5.06) (1.32) (1.80)
Net Cash Flow from Financing Activities (0.77) 51.12 59.57 0.36 80.03
Net Increase/Decrease In Cash (39.31) 13.10 35.66 (21.66) 64.45
Ratios - based on IFRS 30-Jun-10 30-Jun-09 30-Jun-08 30-Jun-07 30-Jun-06
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 0.21¢ 0.15¢ 0.13¢ 0.051¢ n/a
Pre-Tax Profit per Share (11.74¢) (8.91¢) (5.18¢) (6.13¢) (4.50¢)
Operating Margin (5,963.16%) (6,780.67%) (5,247.17%) (12,080.00%) (177,300.00%)
Return on Capital Employed n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (10.06¢) (6.71¢) (4.78¢) (5.25¢) (3.49¢)
Cash Incr/Decr per Share (9.97¢) 3.32¢ 9.04¢ (5.49¢) 16.34¢
Net Asset Value per Share (exc. Intangibles) 24.68¢ 34.62¢ 29.90¢ 19.10¢ 24.77¢
Net Gearing -62.82% -80.70% n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page